Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hydatidiform Mole 1 Gestational Trophoblastic Disease 1

Interventions

Cisplatin 130 Radiotherapy 94 Carboplatin 85 Fluorouracil 79 Paclitaxel 78 Cyclophosphamide 77 Gemcitabine 72 Capecitabine 66 Docetaxel 65 Doxorubicin 60 Oxaliplatin 59 Etoposide 57 Leucovorin 50 Vincristine 47 Chemotherapy, Adjuvant 42 Cytarabine 38 Dexamethasone 35 Drug Therapy 33 Bevacizumab 31 Epirubicin 29 Neoadjuvant Therapy 28 Pemetrexed 27 Tamoxifen 25 Irinotecan 25 Prednisone 24 Rituximab 21 Methotrexate 21 Radiotherapy, Intensity-Modulated 19 apatinib 18 Vinorelbine 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Vacuum Curettage × Clear all

NCT04756713 2022-05-27

ReCure

Brigham and Women's Hospital

Phase 3 Unknown

Hydatidiform Mole, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡